{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:12Z","timestamp":1707524952593},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,15]]},"DOI":"10.7759\/cureus.35032","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T22:27:30Z","timestamp":1676500050000},"source":"Crossref","is-referenced-by-count":0,"title":["Performance of Non-invasive Biomarkers of Liver Fibrosis Amongst Hispanics and African Americans"],"prefix":"10.7759","author":[{"given":"Kesiena","family":"Akpoigbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushbir","family":"Bath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Genao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Culpepper-Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cld.740","article-title":"Con: liver biopsy remains the gold standard to evaluate fibrosis in patients with nonalcoholic fatty liver disease","volume":"13","author":"Berger D","year":"2019","unstructured":"Berger D, Desai V, Janardhan S. Con: liver biopsy remains the gold standard to evaluate fibrosis in patients with nonalcoholic fatty liver disease. Clin Liver Dis. 2019, 13:114-6. 10.1002\/cld.740","journal-title":"Clin Liver Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000621","article-title":"The utility of liver biopsy in 2020","volume":"36","author":"Khalifa A","year":"2020","unstructured":"Khalifa A, Rockey DC. The utility of liver biopsy in 2020. Curr Opin Gastroenterol. 2020, 36:184-91. 10.1097\/MOG.0000000000000621","journal-title":"Curr Opin Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2018-101139","article-title":"Medical liver biopsy: background, indications, procedure and histopathology","volume":"11","author":"Boyd A","year":"2020","unstructured":"Boyd A, Cain O, Chauhan A, Webb GJ. Medical liver biopsy: background, indications, procedure and histopathology. Frontline Gastroenterol. 2020, 11:40-7. 10.1136\/flgastro-2018-101139","journal-title":"Frontline Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-019-0675-8","article-title":"The role of EUS in liver biopsy","volume":"21","author":"Mok SR","year":"2019","unstructured":"Mok SR, Diehl DL. The role of EUS in liver biopsy. Curr Gastroenterol Rep. 2019, 21:6. 10.1007\/s11894-019-0675-8","journal-title":"Curr Gastroenterol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.giec.2018.11.002","article-title":"Endoscopic ultrasound-guided liver biopsy","volume":"29","author":"Diehl DL","year":"2019","unstructured":"Diehl DL. Endoscopic ultrasound-guided liver biopsy. Gastrointest Endosc Clin N Am. 2019, 29:173-86. 10.1016\/j.giec.2018.11.002","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v11.i4.335","article-title":"Endoscopic ultrasound guided liver biopsy for parenchymal liver disease","volume":"11","author":"Shah AR","year":"2019","unstructured":"Shah AR, Al-Hanayneh M, Chowdhry M, Bilal M, Singh S. Endoscopic ultrasound guided liver biopsy for parenchymal liver disease. World J Hepatol. 2019, 11:335-43. 10.4254\/wjh.v11.i4.335","journal-title":"World J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.015","article-title":"Reduced mortality rates following elective percutaneous liver biopsies","volume":"139","author":"West J","year":"2010","unstructured":"West J, Card TR. Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology. 2010, 139:1230-7. 10.1053\/j.gastro.2010.06.015","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13939","article-title":"Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-center experience","volume":"45","author":"Takyar V","year":"2017","unstructured":"Takyar V, Etzion O, Heller T, et al.. Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-center experience. Aliment Pharmacol Ther. 2017, 45:744-53. 10.1111\/apt.13939","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1310\/hct0901-43","article-title":"Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV\/hepatitis C coinfection","volume":"9","author":"Shaheen AA","year":"2008","unstructured":"Shaheen AA, Myers RP. Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV\/hepatitis C coinfection. HIV Clin Trials. 2008, 9:43-51. 10.1310\/hct0901-43","journal-title":"HIV Clin Trials"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson S","year":"2010","unstructured":"McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010, 59:1265-9. 10.1136\/gut.2010.216077","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-44","article-title":"A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)","volume":"11","author":"Ahmad W","year":"2011","unstructured":"Ahmad W, Ijaz B, Javed FT, et al.. A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol. 2011, 11:44. 10.1186\/1471-230X-11-44","journal-title":"BMC Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04560.x","article-title":"Use of the AST to platelet ratio index in HCV\/HIV co-infected patients","volume":"33","author":"Singal AG","year":"2011","unstructured":"Singal AG, Thomassen LV, Gretch DR, Shuhart MC. Use of the AST to platelet ratio index in HCV\/HIV co-infected patients. Aliment Pharmacol Ther. 2011, 33:566-77. 10.1111\/j.1365-2036.2010.04560.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2016.08.006","article-title":"Histological evaluation of non-alcoholic fatty liver disease and its correlation with different noninvasive scoring systems with special reference to fibrosis: a single center experience","volume":"6","author":"Rath MM","year":"2016","unstructured":"Rath MM, Panigrahi MK, Pattnaik K, et al.. Histological evaluation of non-alcoholic fatty liver disease and its correlation with different noninvasive scoring systems with special reference to fibrosis: a single center experience. J Clin Exp Hepatol. 2016, 6:291-6. 10.1016\/j.jceh.2016.08.006","journal-title":"J Clin Exp Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin ZH","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, et al.. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011, 53:726-36. 10.1002\/hep.24105","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25064","article-title":"Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C","volume":"90","author":"Cordie A","year":"2018","unstructured":"Cordie A, Salama A, El-Sharkawy M, et al.. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C. J Med Virol. 2018, 90:1106-11. 10.1002\/jmv.25064","journal-title":"J Med Virol"},{"key":"ref16","article-title":"Comparison of fibrosis scoring tools in predicting liver fibrosis in nonalcoholic fatty liver disease","volume":"63","author":"Arora S","year":"2016","unstructured":"Arora S, Young S, Singal A. Comparison of fibrosis scoring tools in predicting liver fibrosis in nonalcoholic fatty liver disease. Hepatology. 2016, 63:1.","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2007.89","article-title":"Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia","volume":"27","author":"Abdo AA","year":"2007","unstructured":"Abdo AA, Al Swat K, Azzam N, Ahmed S, Al Faleh F. Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia. Ann Saudi Med. 2007, 27:89-93. 10.5144\/0256-4947.2007.89","journal-title":"Ann Saudi Med"},{"key":"ref18","article-title":"Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease","volume":"11","author":"Saadati S","year":"2018","unstructured":"Saadati S, Hekmatdoost A, Hatami B, Mansour A, Zahra Z, Hedayati M, Sadeghi A. Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease. Gastroenterol Hepatol Bed Bench. 2018, 11:S8-13.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.05.001","article-title":"Nonalcoholic fatty liver disease in Latinos","volume":"14","author":"Saab S","year":"2016","unstructured":"Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic fatty liver disease in Latinos. Clin Gastroenterol Hepatol. 2016, 14:5-12. 10.1016\/j.cgh.2015.05.001","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al.. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006, 43:1317-25. 10.1002\/hep.21178","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai CT","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38:518-26. 10.1053\/jhep.2003.50346","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000316","article-title":"Validation of novel fibrosis index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan)","volume":"6","author":"Hussain A","year":"2019","unstructured":"Hussain A, Gul MA, Khalid MU. Validation of novel fibrosis index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan). BMJ Open Gastroenterol. 2019, 6:e000316. 10.1136\/bmjgast-2019-000316","journal-title":"BMJ Open Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.1997.00141.x","article-title":"Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus","volume":"4","author":"Poynard T","year":"1997","unstructured":"Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat. 1997, 4:199-208. 10.1046\/j.1365-2893.1997.00141.x","journal-title":"J Viral Hepat"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4509","article-title":"Classification accuracy and cut point\u2009selection","volume":"31","author":"Liu X","year":"2012","unstructured":"Liu X. Classification accuracy and cut point\u2009selection. Stat Med. 2012, 31:2676-86. 10.1002\/sim.4509","journal-title":"Stat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127699-performance-of-non-invasive-biomarkers-of-liver-fibrosis-amongst-hispanics-and-african-americans","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:56Z","timestamp":1707508316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127699-performance-of-non-invasive-biomarkers-of-liver-fibrosis-amongst-hispanics-and-african-americans"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.35032","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}